Key takeaways from F&O data: FIIs bearish; retail, DIIs hold bullish bets in index futures. Nifty, Bank Nifty options data indicates a bearish stance in the market.
Speaking at BS Manthan, Wood said he remains structurally bullish on Indian equities from a long-term perspective; but cautious in the short-term given the quantum of FII outflows and valuation woes.
The Nifty 50 index has shed nearly 13% in the last five straight months, its longest losing streak since November 1996; equalling its second-worst ever in the 30-year history.
"Wherever (price increase) is absolutely essential, we will have to take some pricing action," Nestle India Managing Director Suresh Narayanan told Reuters
As per the filing, the collaboration will enable Airtel to seamlessly transition to a commercially live, full-scale 5G standalone network over time, bringing the high-end capabilities of 5G
The agreement authorises Venus Remedies to spearhead the clinical development, registration, and commercialisation of MET-X, an innovative metallo-beta- lactamase (MBL) inhibitor
Under the contract, the Zaggle will provide Honasa Consumer with services from Zaggle Zoyer Platform which helps businesses streamline and automate multi-branch and store recurring expenses
Welspun Specialty Solutions will offer 13,25,22,289 rights equity shares for an amount aggregating to Rs 349.86 crore.
Indian investors will have to be patient as FII inflows are not expected in the short to medium term. However, long-term view is intact
"Pursuant to the definitive agreements, INBV will acquire a minority stake of 24.9 per cent of EPL from Blackstone at a purchase price of Rs 240 per share," the filing read
As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 per share
Under the agreement, the company with Mylan Pharma will market and sell two brands Ativan and Pacitane. The contract is for five years within the territory of India
Stock Market outlook this week: Here's a trading guide with key levels to track on the BSE Sensex and the NSE Nifty for the week February 24 - February 28, 2025.
Global brokerage Macquire double upgraded the stock to 'Outperform' for a target of Rs 6,530 per share, as per reports. The brokerage expects growth to pick up in plant and engineering
Roflumilast is used for treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis
M&M shares slipped 6 per cent to Rs 2,666.45 in intra-day trade, its sharpest fall since July 10, 2024, when the stock had plunged 7.8 per cent in intra-day deal, BSE data shows
"I, K Shalini, promoter of MT AR Technologies Limited have acquired from the open market an aggregate of 1,05,000 equity shares of MTAR," the filing read
We wish to inform you that the Company has incorporated a wholly owned Subsidiary by the name "Centuryply Furniture Fittings Limited" at Kolkata on February 18, 2025
Vedanta will be split into five resulting companies - Vedanta, Vedanta Aluminium Metal, Talwandi Sabo Power Limited, Malco Energy, and Vedanta Iron and Steel
Cues from F&O data: Despite holding a bearish view in the February series, data shows FIIs may have added few long positions in Nifty, MidCap Nifty futures; while added short positions in Bank Nifty.